Clinical Trial Update: A Prospecitve Multicenter, Observational Registry Study

View source ↗

Summary

AstraZeneca is sponsoring a prospective multicenter observational registry study on Chronic Kidney Disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Status: RECRUITING